mohs-surgery
(2)
How Schweiger Turned the Dermatologist Wait Into a 160-Office Growth Machine
Eric Schweiger began with one Midtown office and a consumer-grade complaint: seeing a dermatologist took too long. Six messy integrations and at least $155 million of disclosed growth capital later, his group has become a coast-to-coast test of whether convenience and clinical care can scale together.
NovaScan
NovaScan is a Chicago-based clinical-stage oncology company building low-cost, point-of-care devices that detect cancer in real time. Its platform pairs spectral bioimpedance with machine learning around a single biophysical signal - the Cole relaxation frequency, which differs by orders of magnitude between cancerous and healthy tissue. Two lead products, nsCanary for assessing biopsy cores and MarginScan for checking surgical excision margins, aim to deliver answers in seconds instead of the days that conventional pathology can take.